| Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source Y Noguchi, T Tachi, H Teramachi Briefings in bioinformatics 22 (6), bbab347, 2021 | 158 | 2021 |
| The impact of outpatient chemotherapy-related adverse events on the quality of life of breast cancer patients T Tachi, H Teramachi, K Tanaka, S Asano, T Osawa, A Kawashima, ... PLoS One 10 (4), e0124169, 2015 | 91 | 2015 |
| Review of statistical methodologies for detecting drug–drug interactions using spontaneous reporting systems Y Noguchi, T Tachi, H Teramachi Frontiers in pharmacology 10, 1319, 2019 | 69 | 2019 |
| Hyponatremia and hypokalemia as risk factors for falls T Tachi, T Yokoi, C Goto, M Umeda, Y Noguchi, M Yasuda, M Minamitani, ... European journal of clinical nutrition 69 (2), 205-210, 2015 | 59 | 2015 |
| The relationship between dialysis patients' quality of life and caregivers' quality of life H Nagasawa, I Sugita, T Tachi, H Esaki, A Yoshida, Y Kanematsu, ... Frontiers in Pharmacology 9, 770, 2018 | 52 | 2018 |
| The reporting of a disproportionality analysis for drug Safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): explanation and elaboration M Fusaroli, F Salvo, B Begaud, TM AlShammari, A Bate, V Battini, ... Drug safety 47 (6), 585-599, 2024 | 49 | 2024 |
| Comparison of signal detection algorithms based on frequency statistical model for drug-drug interaction using spontaneous reporting systems Y Noguchi, T Tachi, H Teramachi Pharmaceutical Research 37, 1-10, 2020 | 49 | 2020 |
| A new search method using association rule mining for drug-drug interaction based on spontaneous report system Y Noguchi, A Ueno, M Otsubo, H Katsuno, I Sugita, Y Kanematsu, ... Frontiers in pharmacology 9, 197, 2018 | 44 | 2018 |
| The effect of quality of life on medication compliance among dialysis patients H Nagasawa, T Tachi, I Sugita, H Esaki, A Yoshida, Y Kanematsu, ... Frontiers in pharmacology 9, 488, 2018 | 28 | 2018 |
| Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database Y Noguchi, H Katsuno, A Ueno, M Otsubo, A Yoshida, Y Kanematsu, ... Journal of Pharmaceutical Health Care and Sciences 4, 1-8, 2018 | 26 | 2018 |
| Antiepileptic combination therapy with Stevens‐Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database Y Noguchi, M Takaoka, T Hayashi, T Tachi, H Teramachi Epilepsia 61 (9), 1979-1989, 2020 | 25 | 2020 |
| The impact of side effects from outpatient chemotherapy on presenteeism in breast cancer patients: a prospective analysis T Tachi, H Teramachi, K Tanaka, S Asano, T Osawa, A Kawashima, ... SpringerPlus 5, 1-14, 2016 | 24 | 2016 |
| Effects of the number of drugs used on the prevalence of adverse drug reactions in children M Sugioka, T Tachi, T Mizui, A Koyama, A Murayama, H Katsuno, ... Scientific Reports 10 (1), 21341, 2020 | 22 | 2020 |
| Verification of the “upward variation in the reporting odds ratio scores” to detect the signals of drug–drug interactions Y Noguchi, S Yoshizawa, K Aoyama, S Kubo, T Tachi, H Teramachi Pharmaceutics 13 (10), 1531, 2021 | 20 | 2021 |
| Renoprotective effect of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus H Esaki, T Tachi, C Goto, I Sugita, Y Kanematsu, A Yoshida, K Saito, ... Frontiers in Pharmacology 8, 835, 2017 | 20 | 2017 |
| Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database S Xia, H Gong, Y Zhao, L Guo, Y Wang, R Ma, B Zhang, M Sarangdhar, ... Clinical Pharmacology & Therapeutics 114 (1), 211-219, 2023 | 17 | 2023 |
| A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system Y Noguchi, A Ueno, M Otsubo, H Katsuno, I Sugita, Y Kanematsu, ... BMC bioinformatics 19, 1-7, 2018 | 17 | 2018 |
| Factors influencing the use of over-the-counter drugs and health foods/supplements T Tachi, A Yoshida, Y Kanematsu, I Sugita, Y Noguchi, T Osawa, ... Die Pharmazie-An International Journal of Pharmaceutical Sciences 73 (10 …, 2018 | 16 | 2018 |
| Analysis of adverse reactions caused by potentially inappropriate prescriptions and related medical costs that are avoidable using the Beers criteria: the Japanese version and … T Tachi, Y Kanematsu, S Aoyama, H Katsuno, M Otsubo, A Ueno, I Sugita, ... Biological and Pharmaceutical Bulletin 42 (5), 712-720, 2019 | 15 | 2019 |
| Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma T Tachi, M Yasuda, K Usui, M Umeda, K Nagaya, T Osawa, A Ichihashi, ... Die Pharmazie-An International Journal of Pharmaceutical Sciences 70 (10 …, 2015 | 15 | 2015 |
